NxStage Medical, Inc. 4
4 · NxStage Medical, Inc. · Filed Nov 12, 2014
Insider Transaction Report
Form 4
Hershberger Kevin
Chief Accounting Officer
Transactions
- Exercise/Conversion
Common Stock
2014-11-12$9.96/sh+7,824$77,927→ 32,541 total - Exercise/Conversion
Stock Option (Right to Buy)
2014-11-12−7,824→ 12,576 totalExercise: $9.96From: 2010-04-03Exp: 2017-03-02→ Common Stock (7,824 underlying) - Sale
Common Stock
2014-11-12$16.58/sh−11,056$183,308→ 21,485 total
Footnotes (1)
- [F1]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 12, 2014.